Adma Biologics reported $-14815070 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Dynavax Technologies DVAX:US $ 127.67M 96.2M
Minerva Neurosciences NERV:US $ -6965190 1.02M
Omeros OMER:US $ -37438000 2.39M
Takeda 4502:JP 150.52B 152.13B